Total Payments
$1,544
2024 Payments
$170.89
Companies
22
Transactions
67
Medicare Patients
1,045
Medicare Billing
$234,363
Payment Breakdown by Category
Food & Beverage$1,448 (93.8%)
Education$95.51 (6.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,448 | 66 | 93.8% |
| Education | $95.51 | 1 | 6.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $309.18 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $195.98 | 10 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $165.54 | 4 | $0 (2020) |
| Relypsa, Inc. | $120.54 | 7 | $0 (2020) |
| Travere Therapeutics, Inc. | $95.85 | 4 | $0 (2023) |
| Fresenius USA Marketing, Inc. | $92.78 | 4 | $0 (2023) |
| Horizon Therapeutics plc | $77.94 | 4 | $0 (2020) |
| Aurinia Pharma U.S., Inc. | $70.75 | 3 | $0 (2023) |
| Vifor Pharma, Inc. | $57.82 | 3 | $0 (2024) |
| Mallinckrodt LLC | $44.89 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $170.89 | 7 | Lilly USA, LLC ($31.59) |
| 2023 | $365.02 | 16 | Travere Therapeutics, Inc. ($95.85) |
| 2022 | $175.98 | 8 | AstraZeneca Pharmaceuticals LP ($47.32) |
| 2021 | $187.06 | 8 | Amgen Inc. ($89.22) |
| 2020 | $376.80 | 14 | Otsuka America Pharmaceutical, Inc. ($144.74) |
| 2019 | $189.45 | 10 | Amgen Inc. ($78.00) |
| 2018 | $60.02 | 3 | Mallinckrodt LLC ($26.22) |
| 2017 | $18.67 | 1 | Mallinckrodt LLC ($18.67) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/25/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Cardiology | ||||||
| 10/02/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Nephrology | ||||||
| 08/30/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.59 | General |
| Category: Diabetes | ||||||
| 04/26/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/08/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: Hyperkalemia | ||||||
| 12/15/2023 | Amgen Inc. | Parsabiv (Drug), TAVNEOS | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: Nephrology | ||||||
| 10/20/2023 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 09/15/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $22.89 | General |
| 07/14/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $25.57 | General |
| 07/07/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Phosphate binder for ESRD | ||||||
| 06/12/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $24.38 | General |
| 06/08/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Hematology | ||||||
| 05/26/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/19/2023 | Vifor Pharma, Inc. | Veltassa (Drug), Korsuva | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Hyperkalemia | ||||||
| 05/05/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $23.01 | General |
| 04/14/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/31/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $29.02 | General |
| Category: Inflammation | ||||||
| 03/17/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/03/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 02/17/2023 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Hyperkalemia | ||||||
| 01/24/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Endocrinology | ||||||
| 12/15/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/18/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: LUPUS NEPHRITIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 202 | 680 | $143,977 | $60,276 |
| 2022 | 4 | 217 | 586 | $117,634 | $44,825 |
| 2021 | 6 | 259 | 654 | $125,126 | $50,059 |
| 2020 | 9 | 367 | 831 | $203,682 | $79,202 |
Total Patients
1,045
Total Services
2,751
Medicare Billing
$234,363
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 89 | 397 | $66,868 | $28,493 | 42.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 188 | $45,120 | $20,422 | 45.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 75 | 95 | $31,990 | $11,361 | 35.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 123 | 459 | $76,923 | $30,416 | 39.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 69 | 82 | $26,240 | $10,328 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 13 | 25 | $9,575 | $2,173 | 22.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 20 | $4,896 | $1,909 | 39.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 117 | 457 | $76,421 | $30,681 | 40.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 37 | 39 | $18,330 | $7,263 | 39.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 48 | 53 | $16,960 | $6,833 | 40.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 35 | $8,715 | $3,393 | 38.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 25 | $4,250 | $1,753 | 41.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 24 | 45 | $450.00 | $135.00 | 30.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 155 | 502 | $86,944 | $33,783 | 38.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 85 | 97 | $46,079 | $18,197 | 39.5% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 16 | 43 | $27,950 | $11,242 | 40.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 29 | 68 | $17,219 | $6,559 | 38.1% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2020 | 19 | 28 | $15,400 | $6,214 | 40.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 21 | $5,250 | $1,842 | 35.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 19 | $3,230 | $980.30 | 30.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 12 | 12 | $1,200 | $262.89 | 21.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 23 | 41 | $410.00 | $122.46 | 29.9% |
About Janice Desir, MS
Janice Desir, MS is a Nephrology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1811161490.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Janice Desir, MS has received a total of $1,544 in payments from pharmaceutical and medical device companies, with $170.89 received in 2024. These payments were reported across 67 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,448).
As a Medicare-enrolled provider, Desir has provided services to 1,045 Medicare beneficiaries, totaling 2,751 services with total Medicare billing of $234,363. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Bronx, NY
- Active Since 04/15/2008
- Last Updated 10/14/2015
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1811161490
Products in Payments
- Veltassa (Drug) $178.36
- Parsabiv (Drug) $175.78
- LOKELMA (Drug) $171.16
- JYNARQUE (Drug) $165.54
- KRYSTEXXA (Biological) $104.32
- Velphoro (Drug) $92.78
- Parsabiv (Biological) $78.00
- LUPKYNIS (Drug) $70.75
- ACTHAR (Biological) $44.89
- JARDIANCE (Drug) $31.59
- TAVNEOS (Drug) $29.02
- Crysvita (Drug) $27.47
- LEQVIO (Drug) $25.59
- BENLYSTA (Biological) $25.05
- AURYXIA (Drug) $24.78
- Kerendia (Drug) $22.24
- TARPEYO (Drug) $22.22
- FUROSCIX (Drug) $22.15
- Ozempic (Drug) $21.42
- ACCRUFER (Drug) $20.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Bronx
Dr. Bruce Spinowitz, M.d, M.D
Nephrology — Payments: $510,667
Nephrology $510,667
Joel Neugarten, Md, MD
Nephrology — Payments: $384,806
Nephrology $384,806
Enver Akalin, M.d, M.D
Nephrology — Payments: $76,364
Nephrology $76,364
John He, Md, MD
Nephrology — Payments: $24,885
Nephrology $24,885
Abdurhman Ahmed, M.d, M.D
Nephrology — Payments: $12,466
Nephrology $12,466
Dr. Suman Reddy, Md, MD
Nephrology — Payments: $7,783
Nephrology $7,783